Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 2.050
-0.050 (-2.38%)
At close: Feb 12, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 86 million as of February 13, 2026. Its market cap has decreased by -29.04% in one year.
Market Cap
86.00M
Enterprise Value
181.31M
Revenue
1.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.05
Market Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has increased from 8.93M to 86.00M, an increase of 862.84%. That is a compound annual growth rate of 18.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 86.00M | -2.27% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emmessar Biotech & Nutrition | 137.99M |
| Rekvina Laboratories | 134.42M |
| Colinz Laboratories | 130.34M |
| Cian Healthcare | 125.23M |
| Beryl Drugs | 111.32M |
| Shamrock Industrial Company | 110.51M |
| Ortin Global | 110.51M |
| Unjha Formulations | 104.80M |